Stents Bioresorbable

This channel includes news and new technology innovations for bioresorbable stents (BRS). These devices are also referred to as bioabsorbable stents, bioresorbable scaffolds and dissolving stents. BRS are designed as an alternative to permanent metallic stent implants, which cause issues in a small number of patients with in-stent restenosis, late-stent thrombosis and require use of long-term antiplatelet therapy. Metallic stents also cause issues with CT and MRI imaging and may prevent future options for coronary bypass graft (CABG) surgery. BRS are supposed to remove avoid these issues by dissolving and disappearing from the vessel after a period of 2-4 years. This, returns the vessel to its natural state and allows for the return of vasodilatation and vasoconstriction.

 

News | June 24, 2013

June 24, 2013 — Final six and 12-month results of the DIRECT first-in-man...

Elixer bioresorbable stent
Feature | May 16, 2013

May 16, 2013 — Elixir Medical Corp. announced it received CE (Conformité Européenne) mark approval for its DESolve ...

bioresorbable stent, zinc stent

A prototype bioresorbable zinc stent developed by the University of Michigan.

Feature | May 16, 2013

May 15, 2013 — In 2012, more than 3 million people had stents inserted in their coronary arteries. After about six...

News | April 02, 2013

April 2, 2013 — Reva Medical Inc. announced that it has initiated patient enrollment into a...

News | March 20, 2013

March 20, 2013 — Svelte Medical Systems announced treatment of the first patient in the DIRECT II (Direct...

Absorb Bioresorbable Vascular Scaffold Clinical Trial Acc 2013
News | March 15, 2013

March 15, 2013 — Abbott announced positive long-term results for the company's innovative Absorb...

Biosensors BioMatrix

The LEADERS Trial showed that the Biosensors BioMatrix, a drug-eluting stent with a biodegradable abluminal polymer coating, was functionally equivalent to a regular nonbiodegradable stent.

Feature | February 04, 2013 | Kamran Zamanian, Ph.D.

The interventional cardiology market includes, but is not limited to, drug-eluting stents, bare-metal stents,...

Bioresorbable Stent GlobalData Peripheral Artery Disease
News | January 30, 2013

January 30, 2013 — Coronary artery disease and peripheral artery disease are global health issues that affect...

Abbott Absorb bioresorbable stent
Feature | January 08, 2013

January 8, 2013 — Abbott announced the initiation of the ABSORB III clinical trial in patients in the United States...

MiStent Micell Technologies Stents Bioresorbable Clinical Trial Study
News | November 07, 2012

November 7, 2012 — Micell Technologies Inc. announced positive data from two...

Feature | October 31, 2012

October 31, 2012 — Boston Scientific Corp. received CE mark approval for the Synergy...

DESolve Nx Pivotal Trial Bioresorbable Coronary Stent Elixir Cath Lab
Feature | October 30, 2012

October 30, 2012 — Elixir Medical Corp. said enrollment is complete in its 120-patient, pivotal clinical trial...

Feature | October 19, 2012

October 19, 2012 — The 24th Transcatheter Cardiovascular Therapeutics (TCT) conference, sponsored by the...

DESolve Bioresorbable Coronary Scaffold System Clinical Trial
News | October 19, 2012

October 19, 2012 — Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices...

Abbott Bioabsorbable Stent  Absorb
Feature | September 28, 2012

September 28, 2012 — The world’s first drug-eluting bioabsorbable vascular scaffold has been launched and will...

Overlay Init